Xyla

Xyla offers an AI-powered drug discovery copilot called Discovery Companion, designed to accelerate the process from concept to cure. This platform analyzes and synthesizes complex scientific literature, providing actionable insights and driving evidence-based decisions in drug discovery.

Key features:
- Discovery Companion: Engages users with an AI-powered copilot that accelerates the journey from concept to cure through literature-based discovery and validation.
- Comprehensive Literature Analysis: Automatically distills and structures critical, actionable information about genes, diseases, therapies, disease models, and more, grounding its analysis in the most recent evidence.
- Unstructured Data Structuring: Automatically structures research findings, enabling enhanced search through trusted clinical content.

How it works:
1. Users interact with the Discovery Companion by asking specific questions related to genes, diseases, or therapies.
2. The AI responds with detailed, evidence-based answers that synthesize complex research findings into actionable insights.
3. For example, when asked about the impact of gene variants of 4SPAN3 on neural function in Alzheimer's disease, the AI provides a detailed response highlighting the mechanisms and associations involved.

Integrations:
Xyla supports integrations with various scientific literature databases and clinical content platforms.

Use of AI:
Xyla's features are built on advanced generative AI models that can analyze and synthesize complex scientific literature.

Target users:
- Researchers
- Scientists
- Medical professionals involved in drug discovery and development

How to access:
Xyla is available as a web application.